vs
Assertio Holdings, Inc.（ASRT）与Broadway Financial Corp（BYFC）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是Broadway Financial Corp的1.4倍（$13.5M vs $9.4M），Broadway Financial Corp同比增速更快（10.1% vs -57.9%），过去两年Broadway Financial Corp的营收复合增速更高（9.7% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Virtu Financial是一家美国高频交易企业，该公司于2015年在纳斯达克完成上市，在全球金融高频交易领域开展业务。
ASRT vs BYFC — 直观对比
营收规模更大
ASRT
是对方的1.4倍
$9.4M
营收增速更快
BYFC
高出68.0%
-57.9%
两年增速更快
BYFC
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.4M |
| 净利润 | — | $1.0M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | — |
| 净利率 | — | 1934.0% |
| 营收同比 | -57.9% | 10.1% |
| 净利润同比 | — | -21.8% |
| 每股收益（稀释后） | $-4.54 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTBYFC
| Q4 25 | $13.5M | $9.4M | ||
| Q3 25 | $49.5M | $9.0M | ||
| Q2 25 | $29.2M | $8.1M | ||
| Q1 25 | $26.5M | $8.3M | ||
| Q4 24 | $32.2M | $8.6M | ||
| Q3 24 | $29.2M | $8.7M | ||
| Q2 24 | $31.1M | $8.2M | ||
| Q1 24 | $32.4M | $7.8M |
净利润ASRTBYFC
| Q4 25 | — | $1.0M | ||
| Q3 25 | $11.4M | $-23.9M | ||
| Q2 25 | $-16.4M | $752.0K | ||
| Q1 25 | $-13.5M | $-2.7M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-2.9M | $516.0K | ||
| Q2 24 | $-3.7M | $256.0K | ||
| Q1 24 | $-4.5M | $-154.0K |
营业利润率ASRTBYFC
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | -256.2% | ||
| Q2 25 | -27.5% | 12.8% | ||
| Q1 25 | -50.0% | -45.3% | ||
| Q4 24 | -41.9% | 21.7% | ||
| Q3 24 | -10.4% | 8.5% | ||
| Q2 24 | -11.6% | 4.8% | ||
| Q1 24 | -13.4% | -2.9% |
净利率ASRTBYFC
| Q4 25 | — | 1934.0% | ||
| Q3 25 | 23.1% | -264.2% | ||
| Q2 25 | -56.0% | 9.3% | ||
| Q1 25 | -51.1% | -32.3% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -10.0% | 5.9% | ||
| Q2 24 | -11.8% | 3.1% | ||
| Q1 24 | -13.9% | -2.0% |
每股收益（稀释后）ASRTBYFC
| Q4 25 | $-4.54 | $0.02 | ||
| Q3 25 | $0.11 | $-2.86 | ||
| Q2 25 | $-0.17 | $0.00 | ||
| Q1 25 | $-0.14 | $-0.39 | ||
| Q4 24 | $-3.28 | $0.07 | ||
| Q3 24 | $-0.03 | $-0.03 | ||
| Q2 24 | $-0.04 | $0.02 | ||
| Q1 24 | $-0.05 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $10.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $262.8M |
| 总资产 | $267.0M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTBYFC
| Q4 25 | $63.4M | $10.5M | ||
| Q3 25 | $93.4M | $19.7M | ||
| Q2 25 | $98.2M | $29.5M | ||
| Q1 25 | $87.3M | $15.8M | ||
| Q4 24 | $100.1M | $61.4M | ||
| Q3 24 | $88.6M | $97.1M | ||
| Q2 24 | $88.4M | $89.8M | ||
| Q1 24 | $80.7M | $67.1M |
总债务ASRTBYFC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTBYFC
| Q4 25 | $94.0M | $262.8M | ||
| Q3 25 | $105.8M | $261.7M | ||
| Q2 25 | $93.3M | $284.7M | ||
| Q1 25 | $108.5M | $283.6M | ||
| Q4 24 | $121.1M | $285.0M | ||
| Q3 24 | $130.5M | $286.2M | ||
| Q2 24 | $132.2M | $282.1M | ||
| Q1 24 | $134.5M | $281.1M |
总资产ASRTBYFC
| Q4 25 | $267.0M | $1.3B | ||
| Q3 25 | $319.8M | $1.3B | ||
| Q2 25 | $273.8M | $1.2B | ||
| Q1 25 | $286.4M | $1.3B | ||
| Q4 24 | $284.7M | $1.3B | ||
| Q3 24 | $276.0M | $1.4B | ||
| Q2 24 | $279.4M | $1.4B | ||
| Q1 24 | $282.0M | $1.4B |
负债/权益比ASRTBYFC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $230.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-13.0K |
| 自由现金流率自由现金流/营收 | — | -0.1% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 0.22× |
| 过去12个月自由现金流最近4个季度 | — | $2.3M |
8季度趋势，按日历期对齐
经营现金流ASRTBYFC
| Q4 25 | $-30.0M | $230.0K | ||
| Q3 25 | $-4.8M | $3.8M | ||
| Q2 25 | $19.1M | $3.0M | ||
| Q1 25 | $-12.5M | $-4.3M | ||
| Q4 24 | $11.5M | $1.4M | ||
| Q3 24 | $-35.0K | $6.1M | ||
| Q2 24 | $7.4M | $9.8M | ||
| Q1 24 | $7.5M | $-11.7M |
自由现金流ASRTBYFC
| Q4 25 | — | $-13.0K | ||
| Q3 25 | — | $3.7M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $-4.4M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $6.1M | ||
| Q2 24 | — | $9.7M | ||
| Q1 24 | — | $-11.7M |
自由现金流率ASRTBYFC
| Q4 25 | — | -0.1% | ||
| Q3 25 | — | 41.1% | ||
| Q2 25 | — | 37.0% | ||
| Q1 25 | — | -52.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 69.6% | ||
| Q2 24 | — | 118.9% | ||
| Q1 24 | — | -149.7% |
资本支出强度ASRTBYFC
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.7% |
现金转化率ASRTBYFC
| Q4 25 | — | 0.22× | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | 4.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 11.85× | ||
| Q2 24 | — | 38.21× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
BYFC
暂无分部数据
